<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Curr Pain Headache Rep</journal-id><journal-id journal-id-type="iso-abbrev">Curr Pain Headache Rep</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>Current Pain and Headache Reports</journal-title></journal-title-group><issn pub-type="ppub">1531-3433</issn><issn pub-type="epub">1534-3081</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10462493</article-id><article-id pub-id-type="pmcid-ver">PMC10462493.1</article-id><article-id pub-id-type="pmcaid">10462493</article-id><article-id pub-id-type="pmcaiid">10462493</article-id><article-id pub-id-type="pmid">37392334</article-id><article-id pub-id-type="doi">10.1007/s11916-023-01127-0</article-id><article-id pub-id-type="publisher-id">1127</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Acute Pain Medicine (R Urman, Section Editor)</subject></subj-group></article-categories><title-group><article-title>Acute Pain and Development of Opioid Use Disorder: Patient Risk Factors</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Baumann</surname><given-names initials="L">Livia</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bello</surname><given-names initials="C">Corina</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Georg</surname><given-names initials="FM">Filipovic Mark</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Urman</surname><given-names initials="RD">Richard D.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Luedi</surname><given-names initials="MM">Markus M.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-1764-688X</contrib-id><name name-style="western"><surname>Andereggen</surname><given-names initials="L">Lukas</given-names></name><address><email>lukas.andereggen@gmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.413357.7</institution-id><institution-id institution-id-type="ISNI">0000 0000 8704 3732</institution-id><institution>Department of Anaesthesiology and Pain Medicine, </institution><institution>Kantonsspital Aarau, </institution></institution-wrap>Aarau, Switzerland </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.5734.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 0726 5157</institution-id><institution>Faculty of Medicine, </institution><institution>University of Bern, </institution></institution-wrap>Bern, Switzerland </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.411656.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0479 0855</institution-id><institution>Department of Anaesthesiology and Pain Medicine, </institution><institution>Inselspital, Bern University Hospital, University of Bern, </institution></institution-wrap>Bern, Switzerland </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.261331.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2285 7943</institution-id><institution>Department of Anesthesiology, </institution><institution>The Ohio State University, </institution></institution-wrap>Columbus, OH USA </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.413349.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 2294 4705</institution-id><institution>Department of Anaesthesiology and Pain Medicine, </institution><institution>Cantonal Hospital of St, </institution></institution-wrap>Gallen, St. Gallen, Switzerland </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.413357.7</institution-id><institution-id institution-id-type="ISNI">0000 0000 8704 3732</institution-id><institution>Department of Neurosurgery, </institution><institution>Kantonsspital Aarau, </institution></institution-wrap>Aarau, Switzerland </aff></contrib-group><pub-date pub-type="epub"><day>1</day><month>7</month><year>2023</year></pub-date><pub-date pub-type="ppub"><year>2023</year></pub-date><volume>27</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">444181</issue-id><fpage>437</fpage><lpage>444</lpage><history><date date-type="accepted"><day>3</day><month>5</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>07</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>30</day><month>08</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-08-30 02:25:09.377"><day>30</day><month>08</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="11916_2023_Article_1127.pdf"/><abstract id="Abs1"><sec><title>Purpose of Review</title><p id="Par1">Pharmacological therapy for acute pain carries the risk of opioid misuse, with opioid use disorder (OUD) reaching epidemic proportions worldwide in recent years. This narrative review covers the latest research on patient risk factors for opioid misuse in the treatment of acute pain. In particular, we emphasize newer findings and evidence-based strategies to reduce the prevalence of OUD.</p></sec><sec><title>Recent Findings</title><p id="Par2">This narrative review captures a subset of recent advances in the field targeting the literature on patients&#8217; risk factors for OUD in the treatment for acute pain. Besides well-recognized risk factors such as younger age, male sex, lower socioeconomic status, White race, psychiatric comorbidities, and prior substance use, additional challenges such as COVID-19 further aggravated the opioid crisis due to associated stress, unemployment, loneliness, or depression.</p></sec><sec><title>Summary</title><p id="Par3">To reduce OUD, providers should evaluate both the individual patient&#8217;s risk factors and preferences for adequate timing and dosing of opioid prescriptions. Short-term prescription should be considered and patients at-risk closely monitored. The integration of non-opioid analgesics and regional anesthesia to create multimodal, personalized analgesic plans is important. In the management of acute pain, routine prescription of long-acting opioids should be avoided, with implementation of a close monitoring and cessation plan.
</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Acute pain</kwd><kwd>Opioid crisis, Opioid use disorder</kwd><kwd>Patient risk factors</kwd></kwd-group><funding-group><award-group><funding-source><institution>University of Bern</institution></funding-source></award-group><open-access><p>Open access funding provided by University of Bern.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Science+Business Media, LLC, part of Springer Nature 2023</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par4">Opioid use disorder (OUD) is a pattern of harmful opioid use that leads to clinically significant distress or impairment with physical or mental impairments and/or legal consequences [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;]. OUD is defined as any opioid intake fulfilling at least two of the criteria listed in Table <xref rid="Tab1" ref-type="table">1</xref>. Dependence and addiction both are included in the diagnosis of OUD [<xref ref-type="bibr" rid="CR2">2</xref>]. However, it is important to distinguish those two, to reduce stigmatizing (e.g., of patients suffering from chronic pain who developed dependence, a physiologic response to long-term opioid use), enable adequate treatment of true addiction (with long-acting agonists such as methadone or buprenorphine being the only therapeutic option to lower the risk of death in opioid addicts), or to prevent unethical legal consequences for patients who are on such substitution medications (e.g., report to child welfare authorities and subsequent separation from mothers who take methadone) [<xref ref-type="bibr" rid="CR3">3</xref>] (Table <xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Diagnostic criteria for opioid use disorder (adapted by Siddiqui [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;])</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" colspan="2" rowspan="1">- Opioid intake in larger amounts or over a longer period of time than planned</td></tr><tr><td align="left" colspan="2" rowspan="1">- Continuous desire or unsuccessful efforts to control or reduce its usage</td></tr><tr><td align="left" colspan="2" rowspan="1">- Majority of time spent obtaining, using, or recovering from substance use</td></tr><tr><td align="left" colspan="2" rowspan="1">- Cravings to consume opioids</td></tr><tr><td align="left" colspan="2" rowspan="1">- Opioid use leading to failure in daily work or life responsibilities</td></tr><tr><td align="left" colspan="2" rowspan="1">- Continued use despite social problems caused or aggravated by opioid use</td></tr><tr><td align="left" colspan="2" rowspan="1">- Quitting of important activities of daily living as a result of use</td></tr><tr><td align="left" colspan="2" rowspan="1">- Repeated use in situations where opioids can be physically dangerous</td></tr><tr><td align="left" colspan="2" rowspan="1">- Repeated use despite knowing it can cause physical or psychological problems</td></tr><tr><td align="left" colspan="2" rowspan="1">- Development of tolerance (need for rising dosage in order to experience the same effect or decreasing effect with the same amount)</td></tr><tr><td align="left" colspan="2" rowspan="1">- Existing withdrawal symptoms or continued opioid use to avoid those</td></tr></tbody></table></table-wrap><table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Criteria defining dependence and addiction [<xref ref-type="bibr" rid="CR84">84</xref>]</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Dependence</th><th align="left" colspan="1" rowspan="1">Addiction</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"><p>- The need for a substance in order function, e.g., also the use of insulin or anti-hypertensives</p><p>- Physiologic adaptation to taking certain substances over a prolonged period of time</p><p>- Withdrawal symptoms present</p><p>- Generally more common</p></td><td align="left" colspan="1" rowspan="1"><p>- Continued use of a substance, loss of control and strong craving despite negative consequences such as high risks compared to benefits or even harm caused by its use</p><p>- Persistent epigenetic changes even after long-term abstinence</p><p>- Presence or absence withdrawal symptoms</p></td></tr></tbody></table></table-wrap></p><p id="Par5">Since the 1990s, increased prescribing of opioids in high-income countries has led to iatrogenic dependence and later to illicit opioid use. Since 2010, several interventions to reduce the supply and extra-medical use of prescribed opioids, such as prescription monitoring programs and &#8220;pill mill&#8221; laws, have been introduced. These interventions led to a transition from opioid to heroin use from the late 2000s, followed by a third wave starting around 2013 as highly potent synthetic opioids like illicitly manufactured fentanyl entered the market [<xref ref-type="bibr" rid="CR4">4</xref>&#8211;<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par6">Opioids are used to treat acute and chronic pain, such as post-injury pain, or chronic diseases such as cancer [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;]. In surgical patients, a new persistent opioid use is not an uncommon phenomenon and is not significantly different between a minor and major intervention, but rather associated with behavioral disorders [<xref ref-type="bibr" rid="CR8">8</xref>]. Thereby, patients that were on opioids before a surgical procedure had a tenfold increase in the development of persistent postoperative opioid use [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Alarmingly, previously opioid-na&#239;ve patients demonstrated persistent opioid use following surgery ranging from 2 to 6% [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par7">Opioids remain an important and potent measure when treating acute postoperative pain, although recent findings showed that excessive and/or prolonged prescribing, both in-hospital and at discharge, contributes to the current opioid crisis and increase patient harm [<xref ref-type="bibr" rid="CR10">10</xref>&#8226;&#8226;].</p><p id="Par8">In 2017, the global age-standardized rate of opioid dependence per 100,000 people was 510, with the highest estimated prevalence in the USA at 1347 per 100,000 people [<xref ref-type="bibr" rid="CR4">4</xref>]. In the USA, the highest rates of drug use and treatment were noted in northern areas, whereas southern states as well as nonmetropolitan areas had less OUD treatment. Still, the latter may rather point to a limited access to medical support, such as addiction or rehabilitation facilities, naloxone availability, or needle exchange programs, especially in areas with a higher prevalence of minorities [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR11">11</xref>].</p><p id="Par9">Several risk factors for OUD have been identified, including younger age, male sex, lower education level, lower socioeconomic status, race/ethnicity, psychiatric comorbidities [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>], and prior substance use [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR14">14</xref>&#8226;, <xref ref-type="bibr" rid="CR15">15</xref>]. Moreover, the COVID-19 pandemic aggravated the opioid crisis due to increased stress, unemployment rates, isolation and subsequent loneliness, and depression [<xref ref-type="bibr" rid="CR16">16</xref>&#8226;].</p><p id="Par10">In order to reduce OUD, opioid prescriptions should be made after evaluating both, the patient&#8217;s risk factors and individual preferences, and short-term prescribing should be considered. In addition, the opioid use should be monitored and followed closely in those patients at risk for persistent or new chronic opioid use [<xref ref-type="bibr" rid="CR17">17</xref>&#8226;&#8226;]. To minimize opioid usage, non-opioid analgesics and regional anesthesia should be used whenever possible [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR18">18</xref>&#8211;<xref ref-type="bibr" rid="CR22">22</xref>]. Long-acting opioids should either be avoided or used with caution, as they can increase the risk of opioid use dependency [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR10">10</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. In addition, managing OUD should be based on psychosocial behavioral interventions, with medications such as naloxone for acute opioid overdose and methadone or buprenorphine for long-term addiction treatment [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR25">25</xref>&#8211;<xref ref-type="bibr" rid="CR27">27</xref>].</p></sec><sec id="Sec2"><title>Recent Findings</title><p id="Par11">The main risk factors for the development of OUD, such as younger age, male sex, lower education level, lower socioeconomic status, race/ethnicity, psychiatric comorbidities [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;], and prior substance use, have been identified previously [<xref ref-type="bibr" rid="CR14">14</xref>&#8226;]. Besides, there is a lack of information about the situation in most parts of the world, as most of the present literature is centered around the current situation in the USA [<xref ref-type="bibr" rid="CR10">10</xref>&#8226;&#8226;]. Information obtained from the USA can however be used in countries where the opioid crisis has not reached US levels, but a high risk for the development of similar problems exists regarding opioid-linked dependency problems, especially as big pharmaceutical companies expand into low- and middle-income countries [<xref ref-type="bibr" rid="CR10">10</xref>&#8226;&#8226;].</p><p id="Par12">In this narrative review, we capture a subset of recent advances in the field targeting the literature on patients&#8217; risk factors for OUD in the treatment for acute pain.</p><sec id="Sec3"><title>Major Risk Factors for OUD Development</title><p id="Par13">A major risk factor for OUD is the duration of patients&#8217; misuse following initial therapy for acute pain, with no fewer than 6&#8211;19&#160;days of opioid intake increasing dependency by 3.5-fold, and 20&#8211;30&#160;days by 5.5-fold [<xref ref-type="bibr" rid="CR28">28</xref>&#8226;, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. Moreover, the frequently observed intake of higher opioid doses and duration than initially prescribed correlates with the risk of OUD development [<xref ref-type="bibr" rid="CR28">28</xref>&#8226;, <xref ref-type="bibr" rid="CR31">31</xref>]. After adjusting for confounders, it was observed that patients using their own prescriptions were at a greater risk of developing OUD than those who illegally bought or received opioids from family members or friends [<xref ref-type="bibr" rid="CR28">28</xref>&#8226;]. This could be explained by the fact that access to opioids is easier when a patient is in possession of a prescription for potential misuse [<xref ref-type="bibr" rid="CR28">28</xref>&#8226;]. Considering the number of unreported cases of patients with illegal opioid use, more research is needed to better comprehend these use patterns.</p><p id="Par14">Another patient-related risk factor for OUD development in the treatment of acute pain is a history of mental illness such as anxiety disorders, or depression [<xref ref-type="bibr" rid="CR10">10</xref>&#8226;&#8226;], including the morphine&#8217;s mood-elevating effects of opioids [<xref ref-type="bibr" rid="CR28">28</xref>&#8226;]. Moreover, patients with preexisting use of antidepressants, benzodiazepines, or other recreational drugs such as tobacco, alcohol, or cocaine are at an increased risk of developing OUD [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>].</p></sec><sec id="Sec4"><title>Postoperative, Surgical, and Trauma-Related Pain as a Risk Factor for OUD</title><p id="Par15">Adequate pain management is crucial in preventing the development of OUD in the perioperative setting [<xref ref-type="bibr" rid="CR34">34</xref>]. Pain treatment options other than opioids, such as regional anesthesia and non-opioid analgesics, should be given priority [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;]. Undertreatment of pain results in unnecessary suffering and may lead to patients seeking additional pain management. On the other hand, overprescribing of opioids can lead to prolonged use and dependency. Therefore, patients should always receive appropriate follow-up after hospital dismissal and be supported in reducing opioid use [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;].</p><p id="Par16">Current evidence confirms increased risk of developing OUD in patients exposed to opioids following trauma, as early as 3&#160;months after initial exposure [<xref ref-type="bibr" rid="CR35">35</xref>]. Also, patients requiring multiple surgical interventions and intensive care unit (ICU) treatment were more likely to develop OUD [<xref ref-type="bibr" rid="CR14">14</xref>&#8226;]. Therapeutic plans must be carefully considered, as lower incidence of OUD and development of chronic pain are being noted in those receiving multimodal therapy compared to those receiving opioids only [<xref ref-type="bibr" rid="CR14">14</xref>&#8226;], including non-opioid analgesics and regional anesthesia as a base, with the aim of reducing opioid application whenever possible [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR14">14</xref>&#8226;]. Patient preferences should always be taken into account when establishing a personalized pain treatment plan [<xref ref-type="bibr" rid="CR17">17</xref>&#8226;&#8226;]. When opioid prescription is necessary, patients&#8217; individual risks of developing OUD should be evaluated, and prescriptions as well as follow-up meetings and treatment should be coordinated accordingly [<xref ref-type="bibr" rid="CR17">17</xref>&#8226;&#8226;]. The time of opioid application should be kept to a minimal amount, and prescriptions are limited to short-acting opioids when treating acute pain [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR10">10</xref>&#8226;&#8226;]. Regarding extended-release opioids, current recommendations do not support using them in the management of both acute and postoperative pain due to various reasons: they are difficult to manage due to their slow onset time, increase the risk of adverse drug events such as ventilator depression, and finally, increase the risk of persistent postoperative opioid use for longer than 30&#160;days [<xref ref-type="bibr" rid="CR10">10</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR36">36</xref>&#8211;<xref ref-type="bibr" rid="CR39">39</xref>].</p></sec><sec id="Sec5"><title>Risk Factors in Pediatric, Adolescent, and Elderly Patients</title><p id="Par17">Most opioids prescribed for adults are also used by children and are generally well-tolerated, except for codeine [<xref ref-type="bibr" rid="CR40">40</xref>&#8226;&#8226;]. The latter has unpredictable side effects due to different genetic variations in the CYP2D6-phenotype resulting in altered metabolization: children and neonates breastfed by mothers taking codeine may suffer from serious adverse events and even are at risk of death [<xref ref-type="bibr" rid="CR40">40</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR41">41</xref>]. Compared to opioid management in adults, children are mostly prescribed opioids in excess of their analgesic needs [<xref ref-type="bibr" rid="CR40">40</xref>&#8226;&#8226;]. However, after an uneventful pediatric procedure, they should rather provide supply for 3 to 5&#160;days if needed at all [<xref ref-type="bibr" rid="CR40">40</xref>&#8226;&#8226;]. Caregiver education in managing analgesics is important to implement such a safe therapeutic concept, as they often underdose opioids in children following discharge from hospital [<xref ref-type="bibr" rid="CR40">40</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>], while no evidence has been found that opioid use in children leads to later misuse and death when used for acute pain and with correct administration and prescription [<xref ref-type="bibr" rid="CR40">40</xref>&#8226;&#8226;]. Besides, caregivers frequently don&#8217;t receive instructions on safe opioid storage and disposal of eventually unused opioids [<xref ref-type="bibr" rid="CR40">40</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR44">44</xref>]. Of note, opioids prescribed upon discharge have been associated with long-term opioid use in adolescents with prior chronic pain syndrome, substance abuse, or mental health issues; therefore, follow-up meetings arranged by specialized pain services are advised for these patients [<xref ref-type="bibr" rid="CR40">40</xref>&#8226;&#8226;].</p><p id="Par18">In the elderly population (i.e.,&#8201;&gt;&#8201;65&#160;years of age), problematic opioid use and OUD have been increasingly observed, with both illicit and prescription opioids [<xref ref-type="bibr" rid="CR45">45</xref>]. Risk factors for OUD development in this patient cohort include multimorbidity, long-term alcohol misuse, depression, or chronic pain disorder [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. Along with the current therapy plans established from the data of younger adults, elderly patients respond well to opioid agonist therapy, while age is no obstacle to treatment [<xref ref-type="bibr" rid="CR45">45</xref>].</p><p id="Par19">Regardless of age, however, opioid misusage has been linked to psychological factors and single social determinants of pain rather than somatic factors [<xref ref-type="bibr" rid="CR46">46</xref>].</p></sec><sec id="Sec6"><title>Racial Disparities Regarding the Risk of OUD Development</title><p id="Par20">In the management of pain and of OUD, there are significant demographic disparities encountered [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;]. Preventive interventions introduced over the last few years were targeting the White population disregarding minorities, thus leading to a higher prevalence of opioid-related death in the latter group [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;]. In addition, Black patients are more likely to have their pain undertreated and are less likely to receive opioid medication when treated for acute pain [<xref ref-type="bibr" rid="CR17">17</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR47">47</xref>]. Namely, clinicians tend to falsely believe that Black patients are at higher risk for OUD [<xref ref-type="bibr" rid="CR17">17</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR48">48</xref>]. Even with knowledge about patients&#8217; preferences regarding their analgesic therapy and risk factors for substance abuse, racial disparities in treatment for acute pain remain [<xref ref-type="bibr" rid="CR17">17</xref>&#8226;&#8226;]. Additionally, Lee and colleagues noted that apart from a decreased likelihood of receiving opioids for pain relief, African-Americans and Hispanics were less likely to receive any analgesia upon presentation with acute pain at all [<xref ref-type="bibr" rid="CR49">49</xref>&#8226;]. Although some cultural differences may confound these differences in therapy, as, for example, the value of stoicism in some African-American communities limiting adequate pain management, this situation is alarming, especially since this disparity has not changed over the last 30&#160;years [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR49">49</xref>&#8226;]. Interestingly though, the prevalence of OUD among Hispanics and the Latin population is among the highest compared to other ethnicities [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;]. Furthermore, even though minority children in the emergency department were more likely to achieve a&#8201;&#8805;&#8201;2-point reduction in pain on a 10-point scale, they were less likely to obtain optimal pain reduction when being treated in the emergency department [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR47">47</xref>]. Preventive interventions introduced over the last few years have targeted the White population rather than minorities, thus leading to a lower prevalence of opioid-related deaths in the former compared to the latter group [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;]. Thus, a standardized screening program and pain management protocol should be implemented in order to improve acute pain therapies and targeted interventions to reduce OUD in people of all ethnicities [<xref ref-type="bibr" rid="CR1">1</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR50">50</xref>&#8211;<xref ref-type="bibr" rid="CR53">53</xref>].</p></sec><sec id="Sec7"><title>Acute Pain Management in the COVID-19 Era and Its Sequel with Regard to OUD</title><p id="Par21">As of 2019, the COVID-19 pandemic posed new challenges to the global consequences of the opioid crisis: in the USA, patients with OUD were at a higher risk of COVID-19 hospitalization and subsequent worse course of disease, including death, sepsis, kidney failure, and an increased risk of intubation [<xref ref-type="bibr" rid="CR54">54</xref>]. Beside, an increase of non-prescribed drugs, in particular fentanyl, was noted with a major influence on the opioid crisis since the start of the pandemic [<xref ref-type="bibr" rid="CR16">16</xref>&#8226;, <xref ref-type="bibr" rid="CR55">55</xref>]. Potential reasons include increased stress, job loss, loneliness, and depression related to social distancing during the pandemic, which could have aggravated the increased prescription and overuse or intake of illicit drugs, both in people initiating drug intake and people relapsing after prior use [<xref ref-type="bibr" rid="CR56">56</xref>]. In addition, isolation made it more difficult for people to bond with others or to call for immediate help in the case of acute overdosing [<xref ref-type="bibr" rid="CR56">56</xref>].</p><p id="Par22">In general, OUD patients suffering from COVID-19 were older, more likely to be Black or Hispanic with an increased likelihood of having other medical comorbidities like hypertension, cardiovascular disease, chronic pain disorder, diabetes, substance disorders, or mental health issues [<xref ref-type="bibr" rid="CR54">54</xref>]. However, even after accounting for those demographic characteristics and comorbidities, patients with COVID-19 infections in conjunction to OUD were at a higher risk of requiring hospitalization and experiencing medical complications compared to patients without OUD [<xref ref-type="bibr" rid="CR54">54</xref>]. Interestingly, a few comorbidities were noted to be protective in patients with both OUD and COVID-19. Although results are conflicting [<xref ref-type="bibr" rid="CR57">57</xref>&#8211;<xref ref-type="bibr" rid="CR59">59</xref>], studies indicated that asthma was not associated with a higher intubation rate or higher incidence of kidney failure, sepsis, and death [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. This protective effect has been noted before in other COVID-19 cohorts without OUD, potentially being explained by changes in the viral entry receptor expression, the use of steroids, or the chronic inflammatory response [<xref ref-type="bibr" rid="CR54">54</xref>]. Furthermore, another protective effect has been linked to chronic pain syndrome, with fewer intubations being noted in patients infected with COVID-19, as well as a lower rate of kidney failure and mortality [<xref ref-type="bibr" rid="CR54">54</xref>]. In contrast, previous studies showed more severe COVID-19 outcomes in patients treated with long-term opioids, wherefore a firm relationship remains elusive [<xref ref-type="bibr" rid="CR54">54</xref>].</p><p id="Par23">In the COVID-19 era, approximately 22% of opioid-na&#239;ve patients were treated with opioids during hospitalization, with 8% of them receiving a new opioid prescription upon discharge [<xref ref-type="bibr" rid="CR61">61</xref>]. In contrast, in the pre-COVID era, reported rates of a discharge opioid prescription ranged as high as 29% [<xref ref-type="bibr" rid="CR61">61</xref>]. Potential reasons include clinicians making efforts to reduce opioid prescription in general and in COVID-19 patients in particular, for whom opioids are not recommended because of the risk of respiratory impairment [<xref ref-type="bibr" rid="CR61">61</xref>]. Nevertheless, opioid use during hospitalization was associated with a discharge prescription, with every additional day in the hospital increasing the likelihood to receive the latter [<xref ref-type="bibr" rid="CR61">61</xref>].</p><p id="Par24">Appropriate discharge prescriptions are vital and should be consistent with the current practice guidelines of safe opioid stewardship, with close follow&#8208;up to reduce their availability in the community [<xref ref-type="bibr" rid="CR62">62</xref>].</p></sec><sec id="Sec8"><title>OUD Development in Headache Patients</title><p id="Par25">The trend of increasing opioid prescriptions for acute pain has also been noted in patients with headache disorders, despite a lack of evidence of benefit from its use [<xref ref-type="bibr" rid="CR63">63</xref>&#8211;<xref ref-type="bibr" rid="CR66">66</xref>]. Opioid use as a regimen for acute migraine attacks led to an increased rate of returns to the emergency department due a lacking benefit during the acute phase [<xref ref-type="bibr" rid="CR63">63</xref>]. Furthermore, using opioids as the initial treatment for acute headaches was associated with a longer length of hospital stay and led to a high risk of medication overuse headache [<xref ref-type="bibr" rid="CR67">67</xref>]. Depending on the specific type of headaches, opioids should be avoided and primarily treatment should include non-steroidal anti-inflammatory drugs (NSAIDs), neuroleptic antinauseants, triptans, or corticosteroids [<xref ref-type="bibr" rid="CR63">63</xref>]. Second, headache patients should be monitored carefully and followed up systematically in order to reduce the effect on their quality of life and the related burden on society and health care [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR67">67</xref>].</p><p id="Par26">Given the significant drawbacks of opioids, referral to a neurological center with headache specialists is key for patients to ensure correct diagnosis and adequate treatment planning depending on the type of headache [<xref ref-type="bibr" rid="CR68">68</xref>]. In addition, more research is needed to establish specific protocols in the management of headache patients in the acute care setting [<xref ref-type="bibr" rid="CR69">69</xref>&#8211;<xref ref-type="bibr" rid="CR71">71</xref>].</p></sec><sec id="Sec9"><title>OUD Development for Acute Pain Treatment in the US Military</title><p id="Par27">Members of the US military are at particularly high risk of OUD or use of other sedatives [<xref ref-type="bibr" rid="CR72">72</xref>&#8211;<xref ref-type="bibr" rid="CR74">74</xref>]. A 53% increase in drug overdose mortality from 2010 to 2019 has been reported [<xref ref-type="bibr" rid="CR72">72</xref>]. In the US military, 98% of patients treated for combat-related injuries received at least one prescription for opioids, and 83% of patients received an outpatient opioid prescription [<xref ref-type="bibr" rid="CR75">75</xref>&#8226;&#8226;]. Nevertheless, only 4% of patients became sustained opioid users, although many patients who managed to quit opioid usage still had subsequent episodes of opioid misuse [<xref ref-type="bibr" rid="CR75">75</xref>&#8226;&#8226;]. Factors associated with a higher risk of opioid misuse are consistent with risk factors for the general population and included lower socioeconomic status, increased severity of the injury requiring five or more procedures during hospitalization, and comorbid mental health disorders [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR75">75</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR76">76</xref>]. Likewise, Black soldiers were at a lower risk of overusing opioids than White soldiers [<xref ref-type="bibr" rid="CR75">75</xref>&#8226;&#8226;]. Another risk factor identified in the development of long-term opioid dependence among members of the US military included the prescription of long-acting opioids during the first 30&#160;days of an acute pain or physical trauma, rather than using immediate-release opioids [<xref ref-type="bibr" rid="CR77">77</xref>]. Finally, veterans may benefit from peer support to help them reduce their substance use and improve their quality of life and mental health [<xref ref-type="bibr" rid="CR72">72</xref>]. The &#8220;buddy system&#8221; used during military service can be applied to drug use in veteran circles, where the &#8220;buddy&#8221; is trained to administer naloxone or render first aid in case of opioid-related breathing problems [<xref ref-type="bibr" rid="CR72">72</xref>].</p><p id="Par28">In summary, in the acute setting, the use of short-acting opioids is pivotal in members of the military suffering from more severe injuries, additional mental health conditions, lower socioeconomic status, or known previous opioid exposure. Moreover, these patients experience particular benefits from multimodal pain management and regular follow-up visits [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR75">75</xref>&#8226;&#8226;].</p></sec><sec id="Sec10"><title>Prevention Strategies for OUD Development</title><p id="Par29">Prevention strategies for OUD development imply proper assessment and identification of patients at risk for opioid misuse or addiction. However, most screening tools were either based on low-quality studies or were hardly efficient to adequately identify patients at risk for opioid misuse [<xref ref-type="bibr" rid="CR78">78</xref>]. In addition, both acute and chronic pain might not get reported by some patients, in particular by older persons, those with cognitive or mental impairment, and/or patients with substance abuse [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR80">80</xref>]. Better assessment tools along with an improved monitoring system of the prescribed opioids are necessary [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR81">81</xref>]. Importantly, clear communication between clinicians and patients, along with an active involvement of the latter group in the decision-making process towards optimized pain management, is necessary to minimize risks associated with opioid misuse [<xref ref-type="bibr" rid="CR82">82</xref>]. The same approach should be used in children and adolescents, enforcing the engagement of patients themselves and their families in opioid stewardship efforts [<xref ref-type="bibr" rid="CR83">83</xref>].</p></sec></sec><sec id="Sec11"><title>Conclusion</title><p id="Par30">In order to reduce the prevalence of OUD, opioid prescriptions should be made after evaluating both individual patients&#8217; risk factors and preferences. In addition, short-term prescription should be considered and patients at high risk for dependence closely monitored. A shift of standards and protocols towards non-opioid analgesics and regional anesthesia as the basis for multimodal analgesic treatment plans is urgently required. In the management of acute pain, routine prescription of long-acting opioids should be avoided, with implementation of a close monitoring and cessation plan supported by pain specialists.</p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="funding-information"><title>Funding</title><p>Open access funding provided by University of Bern.</p></notes><notes><title>Compliance with Ethical Standards</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of Interest</title><p id="Par31">R. Urman received funding and/or fees from Merck, Medtronic, Pfizer, AxelRx, NIH. Other authors report no conflicts of interest.</p></notes><notes id="FPar2"><title>Human and Animal Rights and Informed Consent</title><p id="Par32">This article does not contain any studies with testing on human or animal subjects performed by any of the authors.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref-list id="BSec1"><title>Papers of particular interest, published recently, have been highlighted as: &#8226; Of importance &#8226;&#8226; Of major importance</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">&#8226;&#8226; Siddiqui N, Urman RD. Opioid use disorder and racial/ethnic health disparities: prevention and management. Curr Pain Headache Rep. 2022;26(2): 129&#8211;37.&#160;<bold>Review about risks and disparities concerning prevalence and treatment of OUD in perioperative and long-term settings, particularly racial disparities.</bold><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11916-022-01010-4</pub-id><pub-id pub-id-type="pmid">35179723</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">Dydyk AM, Jain NK, Gupta M. Opioid use disorder. In: StatPearls. Treasure Island (FL). 2023.</mixed-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szalavitz</surname><given-names>M</given-names></name><name name-style="western"><surname>Rigg</surname><given-names>KK</given-names></name><name name-style="western"><surname>Wakeman</surname><given-names>SE</given-names></name></person-group><article-title>Drug dependence is not addiction-and it matters</article-title><source>Ann Med</source><year>2021</year><volume>53</volume><issue>1</issue><fpage>1989</fpage><lpage>1992</lpage><pub-id pub-id-type="doi">10.1080/07853890.2021.1995623</pub-id><pub-id pub-id-type="pmid">34751058</pub-id><pub-id pub-id-type="pmcid">PMC8583742</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Degenhardt</surname><given-names>L</given-names></name><name name-style="western"><surname>Grebely</surname><given-names>J</given-names></name><name name-style="western"><surname>Stone</surname><given-names>J</given-names></name><name name-style="western"><surname>Hickman</surname><given-names>M</given-names></name><name name-style="western"><surname>Vickerman</surname><given-names>P</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>BDL</given-names></name><etal/></person-group><article-title>Global patterns of opioid use and dependence: harms to populations, interventions, and future action</article-title><source>Lancet</source><year>2019</year><volume>394</volume><issue>10208</issue><fpage>1560</fpage><lpage>1579</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(19)32229-9</pub-id><pub-id pub-id-type="pmid">31657732</pub-id><pub-id pub-id-type="pmcid">PMC7068135</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skolnick</surname><given-names>P</given-names></name></person-group><article-title>The opioid epidemic: crisis and solutions</article-title><source>Annu Rev Pharmacol Toxicol</source><year>2018</year><volume>58</volume><fpage>143</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1146/annurev-pharmtox-010617-052534</pub-id><pub-id pub-id-type="pmid">28968188</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Volkow</surname><given-names>ND</given-names></name><name name-style="western"><surname>Blanco</surname><given-names>C</given-names></name></person-group><article-title>The changing opioid crisis: development, challenges and opportunities</article-title><source>Mol Psychiatry</source><year>2021</year><volume>26</volume><issue>1</issue><fpage>218</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1038/s41380-020-0661-4</pub-id><pub-id pub-id-type="pmid">32020048</pub-id><pub-id pub-id-type="pmcid">PMC7398847</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cragg</surname><given-names>A</given-names></name><name name-style="western"><surname>Hau</surname><given-names>JP</given-names></name><name name-style="western"><surname>Woo</surname><given-names>SA</given-names></name><name name-style="western"><surname>Kitchen</surname><given-names>SA</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Doyle-Waters</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Risk factors for misuse of prescribed opioids: a systematic review and meta-analysis</article-title><source>Ann Emerg Med</source><year>2019</year><volume>74</volume><issue>5</issue><fpage>634</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1016/j.annemergmed.2019.04.019</pub-id><pub-id pub-id-type="pmid">31229388</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brummett</surname><given-names>CM</given-names></name><name name-style="western"><surname>Waljee</surname><given-names>JF</given-names></name><name name-style="western"><surname>Goesling</surname><given-names>J</given-names></name><name name-style="western"><surname>Moser</surname><given-names>S</given-names></name><name name-style="western"><surname>Lin</surname><given-names>P</given-names></name><name name-style="western"><surname>Englesbe</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>New persistent opioid use after minor and major surgical procedures in US adults</article-title><source>JAMA Surg</source><year>2017</year><volume>152</volume><issue>6</issue><fpage>e170504</fpage><pub-id pub-id-type="doi">10.1001/jamasurg.2017.0504</pub-id><pub-id pub-id-type="pmid">28403427</pub-id><pub-id pub-id-type="pmcid">PMC7050825</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kent</surname><given-names>ML</given-names></name><name name-style="western"><surname>Hurley</surname><given-names>RW</given-names></name><name name-style="western"><surname>Oderda</surname><given-names>GM</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>DB</given-names></name><name name-style="western"><surname>Sun</surname><given-names>E</given-names></name><name name-style="western"><surname>Mythen</surname><given-names>M</given-names></name><etal/></person-group><article-title>American society for enhanced recovery and perioperative quality initiative-4 joint consensus statement on persistent postoperative opioid use: definition, incidence, risk factors, and health care system initiatives</article-title><source>Anesth Analg</source><year>2019</year><volume>129</volume><issue>2</issue><fpage>543</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1213/ANE.0000000000003941</pub-id><pub-id pub-id-type="pmid">30897590</pub-id><pub-id pub-id-type="pmcid">PMC6640123</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">&#8226;&#8226; Macintyre PE, Quinlan J, Levy N, Lobo DN. Current issues in the use of opioids for the management of postoperative pain: a review. JAMA Surg. 2022;157(2):158&#8211;66. <bold>Recommendations for reasonable opioid prescribing and opioid stewardship in the postoperative setting (avoidance of long-acting opioids, weaning or reduction of preoperative opioids, management of patient expectations, multimodal analgesia).</bold><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamasurg.2021.6210</pub-id><pub-id pub-id-type="pmid">34878527</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swann</surname><given-names>WL</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SY</given-names></name><name name-style="western"><surname>Schreiber</surname><given-names>TL</given-names></name></person-group><article-title>Urban-rural disparities in opioid use disorder prevention and response activities: a cross-sectional analysis</article-title><source>J Rural Health</source><year>2021</year><volume>37</volume><issue>1</issue><fpage>16</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1111/jrh.12491</pub-id><pub-id pub-id-type="pmid">32639664</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katz</surname><given-names>C</given-names></name><name name-style="western"><surname>El-Gabalawy</surname><given-names>R</given-names></name><name name-style="western"><surname>Keyes</surname><given-names>KM</given-names></name><name name-style="western"><surname>Martins</surname><given-names>SS</given-names></name><name name-style="western"><surname>Sareen</surname><given-names>J</given-names></name></person-group><article-title>Risk factors for incident nonmedical prescription opioid use and abuse and dependence: results from a longitudinal nationally representative sample</article-title><source>Drug Alcohol Depend</source><year>2013</year><volume>132</volume><issue>1&#8211;2</issue><fpage>107</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2013.01.010</pub-id><pub-id pub-id-type="pmid">23399466</pub-id><pub-id pub-id-type="pmcid">PMC5408745</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blanco</surname><given-names>C</given-names></name><name name-style="western"><surname>Rafful</surname><given-names>C</given-names></name><name name-style="western"><surname>Wall</surname><given-names>MM</given-names></name><name name-style="western"><surname>Jin</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Kerridge</surname><given-names>B</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>RP</given-names></name></person-group><article-title>The latent structure and predictors of non-medical prescription drug use and prescription drug use disorders: a national study</article-title><source>Drug Alcohol Depend</source><year>2013</year><volume>133</volume><issue>2</issue><fpage>473</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2013.07.011</pub-id><pub-id pub-id-type="pmid">23962421</pub-id><pub-id pub-id-type="pmcid">PMC3818293</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="other">&#8226; DeJesus J, Shah NR, Franco-Mesa C, Walters ET, Palackic A, Wolf SE. Risk factors for opioid use disorder after severe burns in adults. Am J Surg. 2023;225(2):400&#8211;07.&#160;&#160;<bold>Presents risk factors for patients who developed OUD after burn injuries (opioid exclusive treatment, more frequent surgery, ICU-level care).</bold><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amjsurg.2022.09.023</pub-id><pub-id pub-id-type="pmid">36184330</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boscarino</surname><given-names>JA</given-names></name><name name-style="western"><surname>Rukstalis</surname><given-names>M</given-names></name><name name-style="western"><surname>Hoffman</surname><given-names>SN</given-names></name><name name-style="western"><surname>Han</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Erlich</surname><given-names>PM</given-names></name><name name-style="western"><surname>Gerhard</surname><given-names>GS</given-names></name><etal/></person-group><article-title>Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system</article-title><source>Addiction</source><year>2010</year><volume>105</volume><issue>10</issue><fpage>1776</fpage><lpage>1782</lpage><pub-id pub-id-type="doi">10.1111/j.1360-0443.2010.03052.x</pub-id><pub-id pub-id-type="pmid">20712819</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">&#8226; Niles JK, Gudin J, Radcliff J, Kaufman HW. The opioid epidemic within the COVID-19 pandemic: drug testing in 2020. Popul Health Manag. 2021;24(S1):S43&#8211;S51. <bold>Influence of the COVID-19 pandemic on the opioid crisis (aggravation through stress, job losses, loneliness, and no immediate support in overdose situations).</bold><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/pop.2020.0230</pub-id><pub-id pub-id-type="pmcid">PMC7875135</pub-id><pub-id pub-id-type="pmid">33031013</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="other">&#8226;&#8226; Engel-Rebitzer E, Dolan AR, Aronowitz SV, Shofer FS, Nguemeni Tiako MJ, Schapira MM, et al. Patient preference and risk assessment in opioid prescribing disparities: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2021;4(7):e2118801. <bold>34323984: Shows disparities in receiving opioids in the emergency department according to different races and highlights the importance of taking into account patients&#8217; preferences when treating acute pain.</bold><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2021.18801</pub-id><pub-id pub-id-type="pmcid">PMC8322998</pub-id><pub-id pub-id-type="pmid">34323984</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patzkowski</surname><given-names>MS</given-names></name><name name-style="western"><surname>Patzkowski</surname><given-names>JC</given-names></name></person-group><article-title>Perioperative pain management and avoidance of long-term opioid use</article-title><source>Sports Med Arthrosc Rev</source><year>2019</year><volume>27</volume><issue>3</issue><fpage>112</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1097/JSA.0000000000000244</pub-id><pub-id pub-id-type="pmid">31361721</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burns</surname><given-names>S</given-names></name><name name-style="western"><surname>Urman</surname><given-names>R</given-names></name><name name-style="western"><surname>Pian</surname><given-names>R</given-names></name><name name-style="western"><surname>Coppes</surname><given-names>OJM</given-names></name></person-group><article-title>Reducing new persistent opioid use after surgery: a review of interventions</article-title><source>Curr Pain Headache Rep</source><year>2021</year><volume>25</volume><issue>5</issue><fpage>27</fpage><pub-id pub-id-type="doi">10.1007/s11916-021-00943-6</pub-id><pub-id pub-id-type="pmid">33760983</pub-id><pub-id pub-id-type="pmcid">PMC7990836</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stone</surname><given-names>A</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>A</given-names></name><name name-style="western"><surname>de Boer</surname><given-names>HD</given-names></name><name name-style="western"><surname>Kaye</surname><given-names>AD</given-names></name><name name-style="western"><surname>Fawcett</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Urman</surname><given-names>RD</given-names></name></person-group><article-title>Recommendations for managing opioid-tolerant surgical patients within enhanced recovery pathways</article-title><source>Curr Pain Headache Rep</source><year>2020</year><volume>24</volume><issue>6</issue><fpage>28</fpage><pub-id pub-id-type="doi">10.1007/s11916-020-00856-w</pub-id><pub-id pub-id-type="pmid">32385525</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quinlan</surname><given-names>J</given-names></name><name name-style="western"><surname>Lobo</surname><given-names>DN</given-names></name><name name-style="western"><surname>Levy</surname><given-names>N</given-names></name></person-group><article-title>Postoperative pain management: time to get back on track</article-title><source>Anaesthesia</source><year>2020</year><volume>75</volume><issue>Suppl 1</issue><fpage>e10</fpage><lpage>e13</lpage><pub-id pub-id-type="pmid">31903581</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/anae.14886</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lawal</surname><given-names>OD</given-names></name><name name-style="western"><surname>Gold</surname><given-names>J</given-names></name><name name-style="western"><surname>Murthy</surname><given-names>A</given-names></name><name name-style="western"><surname>Ruchi</surname><given-names>R</given-names></name><name name-style="western"><surname>Bavry</surname><given-names>E</given-names></name><name name-style="western"><surname>Hume</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Rate and risk factors associated with prolonged opioid use after surgery: a systematic review and meta-analysis</article-title><source>JAMA Netw Open</source><year>2020</year><volume>3</volume><issue>6</issue><fpage>e207367</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.7367</pub-id><pub-id pub-id-type="pmid">32584407</pub-id><pub-id pub-id-type="pmcid">PMC7317603</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chou</surname><given-names>R</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>DB</given-names></name><name name-style="western"><surname>de Leon-Casasola</surname><given-names>OA</given-names></name><name name-style="western"><surname>Rosenberg</surname><given-names>JM</given-names></name><name name-style="western"><surname>Bickler</surname><given-names>S</given-names></name><name name-style="western"><surname>Brennan</surname><given-names>T</given-names></name><etal/></person-group><article-title>Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists&#8217; Committee on Regional Anesthesia, Executive Committee, and Administrative Council</article-title><source>J Pain</source><year>2016</year><volume>17</volume><issue>2</issue><fpage>131</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.jpain.2015.12.008</pub-id><pub-id pub-id-type="pmid">26827847</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levy</surname><given-names>N</given-names></name><name name-style="western"><surname>Quinlan</surname><given-names>J</given-names></name><name name-style="western"><surname>El-Boghdadly</surname><given-names>K</given-names></name><name name-style="western"><surname>Fawcett</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Agarwal</surname><given-names>V</given-names></name><name name-style="western"><surname>Bastable</surname><given-names>RB</given-names></name><etal/></person-group><article-title>An international multidisciplinary consensus statement on the prevention of opioid-related harm in adult surgical patients</article-title><source>Anaesthesia</source><year>2021</year><volume>76</volume><issue>4</issue><fpage>520</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1111/anae.15262</pub-id><pub-id pub-id-type="pmid">33027841</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sullivan</surname><given-names>MA</given-names></name><name name-style="western"><surname>Bisaga</surname><given-names>A</given-names></name><name name-style="western"><surname>Pavlicova</surname><given-names>M</given-names></name><name name-style="western"><surname>Carpenter</surname><given-names>KM</given-names></name><name name-style="western"><surname>Choi</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Mishlen</surname><given-names>K</given-names></name><etal/></person-group><article-title>A randomized trial comparing extended-release injectable suspension and oral naltrexone, both combined with behavioral therapy, for the treatment of opioid use disorder</article-title><source>Am J Psychiatry</source><year>2019</year><volume>176</volume><issue>2</issue><fpage>129</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.2018.17070732</pub-id><pub-id pub-id-type="pmid">30336703</pub-id><pub-id pub-id-type="pmcid">PMC6358483</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JD</given-names></name><name name-style="western"><surname>Nunes</surname><given-names>EV</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Novo</surname><given-names>P</given-names></name><name name-style="western"><surname>Bachrach</surname><given-names>K</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>GL</given-names></name><name name-style="western"><surname>Bhatt</surname><given-names>S</given-names></name><etal/></person-group><article-title>Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial</article-title><source>Lancet</source><year>2018</year><volume>391</volume><issue>10118</issue><fpage>309</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(17)32812-X</pub-id><pub-id pub-id-type="pmid">29150198</pub-id><pub-id pub-id-type="pmcid">PMC5806119</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zavod</surname><given-names>A</given-names></name><name name-style="western"><surname>Akerman</surname><given-names>SC</given-names></name><name name-style="western"><surname>Snow</surname><given-names>MM</given-names></name><name name-style="western"><surname>Tierney</surname><given-names>M</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>MA</given-names></name></person-group><article-title>Psychoeducational strategies during outpatient transition to extended-release naltrexone for patients with opioid use disorder</article-title><source>J Am Psychiatr Nurses Assoc</source><year>2019</year><volume>25</volume><issue>4</issue><fpage>272</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1177/1078390318820124</pub-id><pub-id pub-id-type="pmid">30569814</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">&#8226; Thomas AT, Fields KG, Kaye AD, Urman RD. Factors associated with prescription opioid abuse and dependence among those reporting prescription opioid misuse: a retrospective cross-sectional study. Pain Phys. 2022;25(4):E669-E79.&#160;<bold>Shows the importance of opioid treatment duration and its positive correlation with OUD.</bold><pub-id pub-id-type="pmid">35793191</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shah</surname><given-names>A</given-names></name><name name-style="western"><surname>Hayes</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Martin</surname><given-names>BC</given-names></name></person-group><article-title>Characteristics of initial prescription episodes and likelihood of long-term opioid use - United States, 2006&#8211;2015</article-title><source>MMWR Morb Mortal Wkly Rep</source><year>2017</year><volume>66</volume><issue>10</issue><fpage>265</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm6610a1</pub-id><pub-id pub-id-type="pmid">28301454</pub-id><pub-id pub-id-type="pmcid">PMC5657867</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edlund</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Martin</surname><given-names>BC</given-names></name><name name-style="western"><surname>Russo</surname><given-names>JE</given-names></name><name name-style="western"><surname>DeVries</surname><given-names>A</given-names></name><name name-style="western"><surname>Braden</surname><given-names>JB</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>MD</given-names></name></person-group><article-title>The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription</article-title><source>Clin J Pain</source><year>2014</year><volume>30</volume><issue>7</issue><fpage>557</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1097/AJP.0000000000000021</pub-id><pub-id pub-id-type="pmid">24281273</pub-id><pub-id pub-id-type="pmcid">PMC4032801</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="other">Ciesielski T, Iyengar R, Bothra A, Tomala D, Cislo G, Gage BF. A tool to assess risk of de novo opioid abuse or dependence. Am J Med. 2016;129(7):699&#8211;705 e4.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amjmed.2016.02.014</pub-id><pub-id pub-id-type="pmcid">PMC5076552</pub-id><pub-id pub-id-type="pmid">26968469</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaudhary</surname><given-names>MA</given-names></name><name name-style="western"><surname>Bhulani</surname><given-names>N</given-names></name><name name-style="western"><surname>de Jager</surname><given-names>EC</given-names></name><name name-style="western"><surname>Lipsitz</surname><given-names>S</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>NK</given-names></name><name name-style="western"><surname>Sturgeon</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Development and validation of a bedside risk assessment for sustained prescription opioid use after surgery</article-title><source>JAMA Netw Open</source><year>2019</year><volume>2</volume><issue>7</issue><fpage>e196673</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.6673</pub-id><pub-id pub-id-type="pmid">31290987</pub-id><pub-id pub-id-type="pmcid">PMC6624809</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jennings</surname><given-names>MV</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H</given-names></name><name name-style="western"><surname>Rocha</surname><given-names>DB</given-names></name><name name-style="western"><surname>Bianchi</surname><given-names>SB</given-names></name><name name-style="western"><surname>Coombes</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Crist</surname><given-names>RC</given-names></name><etal/></person-group><article-title>Identifying high-risk comorbidities associated with opioid use patterns using electronic health record prescription data</article-title><source>Complex Psychiatry</source><year>2022</year><volume>8</volume><issue>1&#8211;2</issue><fpage>47</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1159/000525313</pub-id><pub-id pub-id-type="pmid">36545045</pub-id><pub-id pub-id-type="pmcid">PMC9669950</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burns</surname><given-names>SL</given-names></name><name name-style="western"><surname>Majdak</surname><given-names>P</given-names></name><name name-style="western"><surname>Urman</surname><given-names>RD</given-names></name></person-group><article-title>Perioperative and periprocedural anesthetic management of opioid tolerant patients and patients with active and medically treated opioid use disorder</article-title><source>Curr Opin Anaesthesiol</source><year>2022</year><volume>35</volume><issue>4</issue><fpage>514</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1097/ACO.0000000000001157</pub-id><pub-id pub-id-type="pmid">35788122</pub-id><pub-id pub-id-type="pmcid">PMC9308736</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="other">Punches BE, Stolz U, Freiermuth CE, Ancona RM, McLean SA, House SL, et al. Predicting at-risk opioid use three months after ed visit for trauma: results from the AURORA study. PLoS One. 2022;17(9):e0273378.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0273378</pub-id><pub-id pub-id-type="pmcid">PMC9506640</pub-id><pub-id pub-id-type="pmid">36149896</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Awadalla</surname><given-names>R</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><name name-style="western"><surname>Kemp-Casey</surname><given-names>A</given-names></name><name name-style="western"><surname>Gnjidic</surname><given-names>D</given-names></name><name name-style="western"><surname>Patanwala</surname><given-names>A</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>J</given-names></name><etal/></person-group><article-title>Impact of an Australian/New Zealand organisational position statement on extended-release opioid prescribing among surgical inpatients: a dual centre before-and-after study</article-title><source>Anaesthesia</source><year>2021</year><volume>76</volume><issue>12</issue><fpage>1607</fpage><lpage>1615</lpage><pub-id pub-id-type="doi">10.1111/anae.15500</pub-id><pub-id pub-id-type="pmid">33954980</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edwards</surname><given-names>DA</given-names></name><name name-style="western"><surname>Hedrick</surname><given-names>TL</given-names></name><name name-style="western"><surname>Jayaram</surname><given-names>J</given-names></name><name name-style="western"><surname>Argoff</surname><given-names>C</given-names></name><name name-style="western"><surname>Gulur</surname><given-names>P</given-names></name><name name-style="western"><surname>Holubar</surname><given-names>SD</given-names></name><etal/></person-group><article-title>American society for enhanced recovery and perioperative quality initiative joint consensus statement on perioperative management of patients on preoperative opioid therapy</article-title><source>Anesth Analg</source><year>2019</year><volume>129</volume><issue>2</issue><fpage>553</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1213/ANE.0000000000004018</pub-id><pub-id pub-id-type="pmid">30768461</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Group TCPM</collab></person-group><article-title>Opioid prescriptions and usage after surgery (OPERAS): protocol for a prospective multicentre observational cohort study of opioid use after surgery</article-title><source>BMJ Open</source><year>2022</year><volume>12</volume><issue>11</issue><fpage>e063577</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2022-063577</pub-id><pub-id pub-id-type="pmcid">PMC9639103</pub-id><pub-id pub-id-type="pmid">36332960</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arwi</surname><given-names>GA</given-names></name><name name-style="western"><surname>Tuffin</surname><given-names>PHR</given-names></name><name name-style="western"><surname>Schug</surname><given-names>SA</given-names></name></person-group><article-title>Evaluating adherence of evidence-based post-operative discharge opioid prescribing guidelines and patient outcomes two weeks post-discharge</article-title><source>J Pain Res</source><year>2022</year><volume>15</volume><fpage>3115</fpage><lpage>3125</lpage><pub-id pub-id-type="doi">10.2147/JPR.S345241</pub-id><pub-id pub-id-type="pmid">36247825</pub-id><pub-id pub-id-type="pmcid">PMC9562842</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="other">&#8226;&#8226; Rosen DM, Alcock MM, Palmer GM. Opioids for acute pain management in children. Anaesth Intensive Care. 2022;50(1&#8211;2):81&#8211;94. <bold>Current guidance for acute pain management with opioids in children (choosing correct opioids, duration, caregiver education, indication for follow-up).</bold><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0310057X211065769</pub-id><pub-id pub-id-type="pmid">35172638</pub-id></mixed-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madadi</surname><given-names>P</given-names></name><name name-style="western"><surname>Koren</surname><given-names>G</given-names></name><name name-style="western"><surname>Cairns</surname><given-names>J</given-names></name><name name-style="western"><surname>Chitayat</surname><given-names>D</given-names></name><name name-style="western"><surname>Gaedigk</surname><given-names>A</given-names></name><name name-style="western"><surname>Leeder</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine</article-title><source>Can Fam Physician</source><year>2007</year><volume>53</volume><issue>1</issue><fpage>33</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">17872605</pub-id><pub-id pub-id-type="pmcid">PMC1952551</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walker</surname><given-names>SM</given-names></name></person-group><article-title>Pain after surgery in children: clinical recommendations</article-title><source>Curr Opin Anaesthesiol</source><year>2015</year><volume>28</volume><issue>5</issue><fpage>570</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1097/ACO.0000000000000227</pub-id><pub-id pub-id-type="pmid">26280822</pub-id><pub-id pub-id-type="pmcid">PMC4617604</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>LD</given-names></name><name name-style="western"><surname>Bai</surname><given-names>X</given-names></name></person-group><article-title>Bibliometric and visual analysis of the current status and trends of postoperative pain in children from 1950&#8211;2021</article-title><source>J Pain Res</source><year>2022</year><volume>15</volume><fpage>3209</fpage><lpage>3222</lpage><pub-id pub-id-type="doi">10.2147/JPR.S380842</pub-id><pub-id pub-id-type="pmid">36267350</pub-id><pub-id pub-id-type="pmcid">PMC9578501</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chalkiadis</surname><given-names>G</given-names></name><name name-style="western"><surname>Goobie</surname><given-names>S</given-names></name><name name-style="western"><surname>Walker</surname><given-names>S</given-names></name></person-group><article-title>Are opioids pediatric anesthesiologists&#8217; sword of Damocles? With great power comes great responsibility and risk</article-title><source>Paediatr Anaesth</source><year>2019</year><volume>29</volume><issue>6</issue><fpage>544</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1111/pan.13659</pub-id><pub-id pub-id-type="pmid">31250500</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dufort</surname><given-names>A</given-names></name><name name-style="western"><surname>Samaan</surname><given-names>Z</given-names></name></person-group><article-title>Problematic opioid use among older adults: epidemiology, adverse outcomes and treatment considerations</article-title><source>Drugs Aging</source><year>2021</year><volume>38</volume><issue>12</issue><fpage>1043</fpage><lpage>1053</lpage><pub-id pub-id-type="doi">10.1007/s40266-021-00893-z</pub-id><pub-id pub-id-type="pmid">34490542</pub-id><pub-id pub-id-type="pmcid">PMC8421190</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="other">Kleinmann B, Wolter T. Opioid consumption in chronic pain patients: role of perceived injustice and other psychological and socioeconomic factors. J Clin Med. 2022;11(3).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jcm11030647</pub-id><pub-id pub-id-type="pmcid">PMC8837077</pub-id><pub-id pub-id-type="pmid">35160101</pub-id></mixed-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="other">Goyal MK, Johnson TJ, Chamberlain JM, Cook L, Webb M, Drendel AL, et al. Racial and ethnic differences in emergency department pain management of children with fractures. Pediatrics. 2020;145(5).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.2019-3370</pub-id><pub-id pub-id-type="pmcid">PMC7193974</pub-id><pub-id pub-id-type="pmid">32312910</pub-id></mixed-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="other">Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 national survey on drug use and health. Ann Intern Med. 2017;167(5):293&#8211;301.<pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/M17-0865</pub-id><pub-id pub-id-type="pmid">28761945</pub-id></mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="other">&#8226; Lee P, Le Saux M, Siegel R, Goyal M, Chen C, Ma Y, et al. Racial and ethnic disparities in the management of acute pain in US emergency departments: Meta-analysis and systematic review. Am J Emerg Med. 2019;37(9): 1770&#8211;77. <bold>Systematic review showing that minority groups were less likely to receive analgesia for acute pain than white patients.</bold><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajem.2019.06.014</pub-id><pub-id pub-id-type="pmid">31186154</pub-id></mixed-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romero</surname><given-names>R</given-names></name><name name-style="western"><surname>Friedman</surname><given-names>JR</given-names></name><name name-style="western"><surname>Goodman-Meza</surname><given-names>D</given-names></name><name name-style="western"><surname>Shover</surname><given-names>CL</given-names></name></person-group><article-title>US drug overdose mortality rose faster among Hispanics than non-Hispanics from 2010 to 2021</article-title><source>Drug Alcohol Depend</source><year>2023</year><volume>246</volume><fpage>109859</fpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2023.109859</pub-id><pub-id pub-id-type="pmid">37031488</pub-id><pub-id pub-id-type="pmcid">PMC11195918</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="other">Flores MW, Sharp A, Lu F, Cook BL. Examining racial/ethnic differences in patterns of opioid prescribing: results from an urban safety-net healthcare system. J Racial Ethn Health Dispart. 2023;1&#8211;11.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40615-023-01555-z</pub-id><pub-id pub-id-type="pmcid">PMC9997438</pub-id><pub-id pub-id-type="pmid">36892815</pub-id></mixed-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Letchuman</surname><given-names>V</given-names></name><name name-style="western"><surname>He</surname><given-names>L</given-names></name><name name-style="western"><surname>Mummaneni</surname><given-names>PV</given-names></name><name name-style="western"><surname>Agarwal</surname><given-names>N</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Shabani</surname><given-names>S</given-names></name><etal/></person-group><article-title>Racial differences in postoperative opioid prescribing practices in spine surgical patients</article-title><source>Neurosurgery</source><year>2023</year><volume>92</volume><issue>3</issue><fpage>490</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1227/neu.0000000000002227</pub-id><pub-id pub-id-type="pmid">36700672</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kene</surname><given-names>M</given-names></name><name name-style="western"><surname>Bhopale</surname><given-names>S</given-names></name><name name-style="western"><surname>Eaton</surname><given-names>A</given-names></name><name name-style="western"><surname>Awsare</surname><given-names>SV</given-names></name><name name-style="western"><surname>Reed</surname><given-names>ME</given-names></name></person-group><article-title>Opioid safety initiative associated with decreased emergency department opioid prescribing</article-title><source>Am J Manag Care</source><year>2022</year><volume>28</volume><issue>6</issue><fpage>e203</fpage><lpage>e211</lpage><pub-id pub-id-type="doi">10.37765/ajmc.2022.89158</pub-id><pub-id pub-id-type="pmid">35738227</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krawczyk</surname><given-names>N</given-names></name><name name-style="western"><surname>Rivera</surname><given-names>BD</given-names></name><name name-style="western"><surname>Basaraba</surname><given-names>C</given-names></name><name name-style="western"><surname>Corbeil</surname><given-names>T</given-names></name><name name-style="western"><surname>Allen</surname><given-names>B</given-names></name><name name-style="western"><surname>Schultebraucks</surname><given-names>K</given-names></name><etal/></person-group><article-title>COVID-19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systems</article-title><source>Addiction</source><year>2023</year><volume>118</volume><issue>5</issue><fpage>857</fpage><lpage>869</lpage><pub-id pub-id-type="doi">10.1111/add.16105</pub-id><pub-id pub-id-type="pmid">36459420</pub-id><pub-id pub-id-type="pmcid">PMC9878119</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leonhardt</surname><given-names>MM</given-names></name><name name-style="western"><surname>Spartz</surname><given-names>JR</given-names></name><name name-style="western"><surname>Shankar</surname><given-names>A</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>SA</given-names></name></person-group><article-title>Fatal drug use in the COVID-19 pandemic response: changing trends in drug-involved deaths before and after stay-at-home orders in Louisiana</article-title><source>Front Public Health</source><year>2023</year><volume>11</volume><fpage>1117841</fpage><pub-id pub-id-type="doi">10.3389/fpubh.2023.1117841</pub-id><pub-id pub-id-type="pmid">37113181</pub-id><pub-id pub-id-type="pmcid">PMC10126274</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bech</surname><given-names>P</given-names></name><name name-style="western"><surname>Allerup</surname><given-names>A</given-names></name></person-group><article-title>A categorical approach to depression by a three-dimensional system</article-title><source>Psychopathology</source><year>1986</year><volume>19</volume><issue>6</issue><fpage>327</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1159/000284457</pub-id><pub-id pub-id-type="pmid">3303101</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hussein</surname><given-names>MH</given-names></name><name name-style="western"><surname>Elshazli</surname><given-names>RM</given-names></name><name name-style="western"><surname>Attia</surname><given-names>AS</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>TP</given-names></name><name name-style="western"><surname>Aboueisha</surname><given-names>M</given-names></name><name name-style="western"><surname>Munshi</surname><given-names>R</given-names></name><etal/></person-group><article-title>Asthma and COVID-19; different entities, same outcome: a meta-analysis of 107,983 patients</article-title><source>J Asthma</source><year>2022</year><volume>59</volume><issue>5</issue><fpage>851</fpage><lpage>858</lpage><pub-id pub-id-type="doi">10.1080/02770903.2021.1881970</pub-id><pub-id pub-id-type="pmid">33504226</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lombardi</surname><given-names>C</given-names></name><name name-style="western"><surname>Gani</surname><given-names>F</given-names></name><name name-style="western"><surname>Berti</surname><given-names>A</given-names></name><name name-style="western"><surname>Comberiati</surname><given-names>P</given-names></name><name name-style="western"><surname>Peroni</surname><given-names>D</given-names></name><name name-style="western"><surname>Cottini</surname><given-names>M</given-names></name></person-group><article-title>Asthma and COVID-19: a dangerous liaison?</article-title><source>Asthma Res Pract</source><year>2021</year><volume>7</volume><issue>1</issue><fpage>9</fpage><pub-id pub-id-type="doi">10.1186/s40733-021-00075-z</pub-id><pub-id pub-id-type="pmid">34261543</pub-id><pub-id pub-id-type="pmcid">PMC8279806</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhattarai</surname><given-names>A</given-names></name><name name-style="western"><surname>Dhakal</surname><given-names>G</given-names></name><name name-style="western"><surname>Shah</surname><given-names>S</given-names></name><name name-style="western"><surname>Subedi</surname><given-names>A</given-names></name><name name-style="western"><surname>Sah</surname><given-names>SK</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>SK</given-names></name></person-group><article-title>Effect of preexisting asthma on the risk of ICU admission, intubation, and death from COVID-19: a systematic review and meta-analysis</article-title><source>Interdiscip Perspect Infect Dis</source><year>2022</year><volume>2022</volume><fpage>8508489</fpage><pub-id pub-id-type="doi">10.1155/2022/8508489</pub-id><pub-id pub-id-type="pmid">35677466</pub-id><pub-id pub-id-type="pmcid">PMC9168826</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hussein</surname><given-names>MH</given-names></name><name name-style="western"><surname>Toraih</surname><given-names>EA</given-names></name><name name-style="western"><surname>Attia</surname><given-names>AS</given-names></name><name name-style="western"><surname>Burley</surname><given-names>N</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>AD</given-names></name><name name-style="western"><surname>Roos</surname><given-names>J</given-names></name><etal/></person-group><article-title>Asthma in COVID-19 patients: an extra chain fitting around the neck?</article-title><source>Respir Med</source><year>2020</year><volume>175</volume><fpage>106205</fpage><pub-id pub-id-type="doi">10.1016/j.rmed.2020.106205</pub-id><pub-id pub-id-type="pmid">33217538</pub-id><pub-id pub-id-type="pmcid">PMC7657611</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Delaney</surname><given-names>LD</given-names></name><name name-style="western"><surname>Bicket</surname><given-names>MC</given-names></name><name name-style="western"><surname>Hu</surname><given-names>HM</given-names></name><name name-style="western"><surname>O'Malley</surname><given-names>M</given-names></name><name name-style="western"><surname>McLaughlin</surname><given-names>E</given-names></name><name name-style="western"><surname>Flanders</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Opioid and benzodiazepine prescribing after COVID-19 hospitalization</article-title><source>J Hosp Med</source><year>2022</year><volume>17</volume><issue>7</issue><fpage>539</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1002/jhm.12842</pub-id><pub-id pub-id-type="pmid">35621024</pub-id><pub-id pub-id-type="pmcid">PMC9347718</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kasanagottu</surname><given-names>K</given-names></name><name name-style="western"><surname>Herzig</surname><given-names>SJ</given-names></name></person-group><article-title>Opioids, benzodiazepines, and COVID-19: A recipe for risk</article-title><source>J Hosp Med</source><year>2022</year><volume>17</volume><issue>7</issue><fpage>580</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1002/jhm.12889</pub-id><pub-id pub-id-type="pmid">35700321</pub-id><pub-id pub-id-type="pmcid">PMC9349968</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giamberardino</surname><given-names>MA</given-names></name><name name-style="western"><surname>Affaitati</surname><given-names>G</given-names></name><name name-style="western"><surname>Costantini</surname><given-names>R</given-names></name><name name-style="western"><surname>Guglielmetti</surname><given-names>M</given-names></name><name name-style="western"><surname>Martelletti</surname><given-names>P</given-names></name></person-group><article-title>Acute headache management in emergency department</article-title><source>A narrative review Intern Emerg Med</source><year>2020</year><volume>15</volume><issue>1</issue><fpage>109</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1007/s11739-019-02266-2</pub-id><pub-id pub-id-type="pmid">31893348</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naeem</surname><given-names>F</given-names></name><name name-style="western"><surname>Schramm</surname><given-names>C</given-names></name><name name-style="western"><surname>Friedman</surname><given-names>BW</given-names></name></person-group><article-title>Emergent management of primary headache: a review of current literature</article-title><source>Curr Opin Neurol</source><year>2018</year><volume>31</volume><issue>3</issue><fpage>286</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1097/WCO.0000000000000547</pub-id><pub-id pub-id-type="pmid">29461426</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levin</surname><given-names>M</given-names></name></person-group><article-title>Opioids in headache</article-title><source>Headache</source><year>2014</year><volume>54</volume><issue>1</issue><fpage>12</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1111/head.12266</pub-id><pub-id pub-id-type="pmid">24127913</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bello</surname><given-names>C</given-names></name><name name-style="western"><surname>Andereggen</surname><given-names>L</given-names></name><name name-style="western"><surname>Luedi</surname><given-names>MM</given-names></name><name name-style="western"><surname>Beilstein</surname><given-names>CM</given-names></name></person-group><article-title>Postcraniotomy headache: etiologies and treatments</article-title><source>Curr Pain Headache Rep</source><year>2022</year><volume>26</volume><issue>5</issue><fpage>357</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1007/s11916-022-01036-8</pub-id><pub-id pub-id-type="pmid">35230591</pub-id><pub-id pub-id-type="pmcid">PMC9061675</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>UK</given-names></name><name name-style="western"><surname>Malik</surname><given-names>P</given-names></name><name name-style="western"><surname>Shah</surname><given-names>D</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>A</given-names></name><name name-style="western"><surname>Bhela</surname><given-names>J</given-names></name><name name-style="western"><surname>Chauhan</surname><given-names>B</given-names></name><etal/></person-group><article-title>The opioid epidemic and primary headache disorders: a nationwide population-based study</article-title><source>Cureus</source><year>2020</year><volume>12</volume><issue>8</issue><fpage>e9743</fpage><pub-id pub-id-type="pmid">32944458</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.9743</pub-id><pub-id pub-id-type="pmcid">PMC7489777</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Negro</surname><given-names>A</given-names></name><name name-style="western"><surname>Spuntarelli</surname><given-names>V</given-names></name><name name-style="western"><surname>Sciattella</surname><given-names>P</given-names></name><name name-style="western"><surname>Martelletti</surname><given-names>P</given-names></name></person-group><article-title>Rapid referral for headache management from emergency department to headache centre: four years data</article-title><source>J Headache Pain</source><year>2020</year><volume>21</volume><issue>1</issue><fpage>25</fpage><pub-id pub-id-type="doi">10.1186/s10194-020-01094-6</pub-id><pub-id pub-id-type="pmid">32169031</pub-id><pub-id pub-id-type="pmcid">PMC7071765</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmed</surname><given-names>ZA</given-names></name><name name-style="western"><surname>Nacopoulos</surname><given-names>DA</given-names></name><name name-style="western"><surname>John</surname><given-names>S</given-names></name><name name-style="western"><surname>Papesh</surname><given-names>N</given-names></name><name name-style="western"><surname>Levine</surname><given-names>D</given-names></name><name name-style="western"><surname>Bamford</surname><given-names>CC</given-names></name></person-group><article-title>An algorithm for opioid and barbiturate reduction in the acute management of headache in the emergency department</article-title><source>Headache</source><year>2017</year><volume>57</volume><issue>1</issue><fpage>71</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1111/head.12961</pub-id><pub-id pub-id-type="pmid">27861834</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doretti</surname><given-names>A</given-names></name><name name-style="western"><surname>Shestaritc</surname><given-names>I</given-names></name><name name-style="western"><surname>Ungaro</surname><given-names>D</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JI</given-names></name><name name-style="western"><surname>Lymperopoulos</surname><given-names>L</given-names></name><name name-style="western"><surname>Kokoti</surname><given-names>L</given-names></name><etal/></person-group><article-title>Headaches in the emergency department -a survey of patients' characteristics, facts and needs</article-title><source>J Headache Pain</source><year>2019</year><volume>20</volume><issue>1</issue><fpage>100</fpage><pub-id pub-id-type="doi">10.1186/s10194-019-1053-5</pub-id><pub-id pub-id-type="pmid">31690261</pub-id><pub-id pub-id-type="pmcid">PMC6833179</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maciel</surname><given-names>CB</given-names></name><name name-style="western"><surname>Barlow</surname><given-names>B</given-names></name><name name-style="western"><surname>Lucke-Wold</surname><given-names>B</given-names></name><name name-style="western"><surname>Gobinathan</surname><given-names>A</given-names></name><name name-style="western"><surname>Abu-Mowis</surname><given-names>Z</given-names></name><name name-style="western"><surname>Peethala</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Acute headache management for patients with subarachnoid hemorrhage: an international survey of health care providers</article-title><source>Neurocrit Care</source><year>2023</year><volume>38</volume><issue>2</issue><fpage>395</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1007/s12028-022-01571-7</pub-id><pub-id pub-id-type="pmid">35915347</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><mixed-citation publication-type="other">Bennett AS, Guarino H, Britton PC, O'Brien-Mazza D, Cook SH, Taveras F, et al. U.S. Military veterans and the opioid overdose crisis: a review of risk factors and prevention efforts. Ann Med. 2022;54(1):1826&#8211;38.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/07853890.2022.2092896</pub-id><pub-id pub-id-type="pmcid">PMC9262363</pub-id><pub-id pub-id-type="pmid">35792749</pub-id></mixed-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beyer</surname><given-names>CA</given-names></name><name name-style="western"><surname>Poltavskiy</surname><given-names>E</given-names></name><name name-style="western"><surname>Walker</surname><given-names>LE</given-names></name><name name-style="western"><surname>Pettey</surname><given-names>W</given-names></name><name name-style="western"><surname>Suo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Redd</surname><given-names>A</given-names></name><etal/></person-group><article-title>Persistent opioid use after combat injury and subsequent long-term risk of abuse: a retrospective cohort study</article-title><source>Ann Surg</source><year>2021</year><volume>274</volume><issue>6</issue><fpage>e957</fpage><lpage>e965</lpage><pub-id pub-id-type="doi">10.1097/SLA.0000000000003658</pub-id><pub-id pub-id-type="pmid">31714315</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelley</surname><given-names>ML</given-names></name><name name-style="western"><surname>Bravo</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Votaw</surname><given-names>VR</given-names></name><name name-style="western"><surname>Stein</surname><given-names>E</given-names></name><name name-style="western"><surname>Redman</surname><given-names>JC</given-names></name><name name-style="western"><surname>Witkiewitz</surname><given-names>K</given-names></name></person-group><article-title>Opioid and sedative misuse among veterans wounded in combat</article-title><source>Addict Behav</source><year>2019</year><volume>92</volume><fpage>168</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1016/j.addbeh.2018.12.007</pub-id><pub-id pub-id-type="pmid">30640149</pub-id><pub-id pub-id-type="pmcid">PMC10617000</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><mixed-citation publication-type="other">&#8226;&#8226; Dalton MK, Manful A, Jarman MP, Pisano AJ, Learn PA, Koehlmoos TP, et al. Long-term prescription opioid use among US military service members injured in combat. J Trauma Acute Care Surg. 2021;91(2S Suppl 2):S213&#8211;S20.&#160;<bold>Illustration of opioid prescription and usage dynamic in US military members after injury, with 98% of patients receiving opioids and only 4% becoming sustained users, although many of them have subsequent opioid use episodes. Patient risk factors for higher opioid use correspond with the general population (lower socioeconomic status, worse injury, comorbid mental health conditions).</bold><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/TA.0000000000003133</pub-id><pub-id pub-id-type="pmid">34324474</pub-id></mixed-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaudhary</surname><given-names>MA</given-names></name><name name-style="western"><surname>von Keudell</surname><given-names>A</given-names></name><name name-style="western"><surname>Bhulani</surname><given-names>N</given-names></name><name name-style="western"><surname>de Jager</surname><given-names>EC</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>NK</given-names></name><name name-style="western"><surname>Koehlmoos</surname><given-names>T</given-names></name><etal/></person-group><article-title>Prior prescription opioid use and its influence on opioid requirements after orthopedic trauma</article-title><source>J Surg Res</source><year>2019</year><volume>238</volume><fpage>29</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2019.01.016</pub-id><pub-id pub-id-type="pmid">30735963</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adams</surname><given-names>RS</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>CP</given-names></name><name name-style="western"><surname>Ritter</surname><given-names>GA</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S</given-names></name><name name-style="western"><surname>Saadoun</surname><given-names>M</given-names></name><name name-style="western"><surname>Williams</surname><given-names>TV</given-names></name><etal/></person-group><article-title>Predictors of postdeployment prescription opioid receipt and long-term prescription opioid utilization among army active duty soldiers</article-title><source>Mil Med</source><year>2019</year><volume>184</volume><issue>1&#8211;2</issue><fpage>e101</fpage><lpage>e109</lpage><pub-id pub-id-type="doi">10.1093/milmed/usy162</pub-id><pub-id pub-id-type="pmid">30007291</pub-id><pub-id pub-id-type="pmcid">PMC6329665</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klimas</surname><given-names>J</given-names></name><name name-style="western"><surname>Gorfinkel</surname><given-names>L</given-names></name><name name-style="western"><surname>Fairbairn</surname><given-names>N</given-names></name><name name-style="western"><surname>Amato</surname><given-names>L</given-names></name><name name-style="western"><surname>Ahamad</surname><given-names>K</given-names></name><name name-style="western"><surname>Nolan</surname><given-names>S</given-names></name><etal/></person-group><article-title>Strategies to identify patient risks of prescription opioid addiction when initiating opioids for pain: a systematic review</article-title><source>JAMA Netw Open</source><year>2019</year><volume>2</volume><issue>5</issue><fpage>e193365</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.3365</pub-id><pub-id pub-id-type="pmid">31050783</pub-id><pub-id pub-id-type="pmcid">PMC6503484</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>F</given-names></name><name name-style="western"><surname>Feng</surname><given-names>A</given-names></name><name name-style="western"><surname>Han</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Risk factors and prevention strategies for postoperative opioid abuse</article-title><source>Pain Res Manag</source><year>2019</year><volume>2019</volume><fpage>7490801</fpage><pub-id pub-id-type="doi">10.1155/2019/7490801</pub-id><pub-id pub-id-type="pmid">31360271</pub-id><pub-id pub-id-type="pmcid">PMC6652031</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bangham</surname><given-names>C</given-names></name><name name-style="western"><surname>Cunnington</surname><given-names>S</given-names></name><name name-style="western"><surname>Fielman</surname><given-names>S</given-names></name><name name-style="western"><surname>Hurley</surname><given-names>M</given-names></name><name name-style="western"><surname>Gergerian</surname><given-names>S</given-names></name><name name-style="western"><surname>Greece</surname><given-names>JA</given-names></name></person-group><article-title>Using formative evaluation of a community-based opioid overdose prevention program to inform strategic communication for adoption, implementation, and sustainability</article-title><source>BMC Public Health</source><year>2023</year><volume>23</volume><issue>1</issue><fpage>341</fpage><pub-id pub-id-type="doi">10.1186/s12889-023-15229-2</pub-id><pub-id pub-id-type="pmid">36793001</pub-id><pub-id pub-id-type="pmcid">PMC9930042</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Webster</surname><given-names>LR</given-names></name></person-group><article-title>Risk factors for opioid-use disorder and overdose</article-title><source>Anesth Analg</source><year>2017</year><volume>125</volume><issue>5</issue><fpage>1741</fpage><lpage>1748</lpage><pub-id pub-id-type="doi">10.1213/ANE.0000000000002496</pub-id><pub-id pub-id-type="pmid">29049118</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shrestha</surname><given-names>S</given-names></name><name name-style="western"><surname>Khatiwada</surname><given-names>AP</given-names></name><name name-style="western"><surname>Sapkota</surname><given-names>B</given-names></name><name name-style="western"><surname>Sapkota</surname><given-names>S</given-names></name><name name-style="western"><surname>Poudel</surname><given-names>P</given-names></name><name name-style="western"><surname>Kc</surname><given-names>B</given-names></name><etal/></person-group><article-title>What is &#8220;opioid stewardship&#8221;? An overview of current definitions and proposal for a universally acceptable definition</article-title><source>J Pain Res</source><year>2023</year><volume>16</volume><fpage>383</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.2147/JPR.S389358</pub-id><pub-id pub-id-type="pmid">36798077</pub-id><pub-id pub-id-type="pmcid">PMC9926985</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelley-Quon</surname><given-names>LI</given-names></name><name name-style="western"><surname>Kirkpatrick</surname><given-names>MG</given-names></name><name name-style="western"><surname>Ricca</surname><given-names>RL</given-names></name><name name-style="western"><surname>Baird</surname><given-names>R</given-names></name><name name-style="western"><surname>Harbaugh</surname><given-names>CM</given-names></name><name name-style="western"><surname>Brady</surname><given-names>A</given-names></name><etal/></person-group><article-title>Guidelines for opioid prescribing in children and adolescents after surgery: an expert panel opinion</article-title><source>JAMA Surg</source><year>2021</year><volume>156</volume><issue>1</issue><fpage>76</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1001/jamasurg.2020.5045</pub-id><pub-id pub-id-type="pmid">33175130</pub-id><pub-id pub-id-type="pmcid">PMC8995055</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O'Brien</surname><given-names>CP</given-names></name><name name-style="western"><surname>Volkow</surname><given-names>N</given-names></name><name name-style="western"><surname>Li</surname><given-names>TK</given-names></name></person-group><article-title>What&#8217;s in a word? Addiction versus dependence in DSM-V</article-title><source>Am J Psychiatry</source><year>2006</year><volume>163</volume><issue>5</issue><fpage>764</fpage><lpage>765</lpage><pub-id pub-id-type="doi">10.1176/ajp.2006.163.5.764</pub-id><pub-id pub-id-type="pmid">16648309</pub-id></element-citation></ref></ref-list></ref-list></back></article></pmc-articleset>